Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Transdermal drug patches are patches that are attached to the skin and contain drugs. The drugs from the patches are used to deliver multiple drugs into the body.
The market data drafted in this report includes key market parameters such as market size, share, key drivers, transdermal drug patches market trends, major key players, or leading brands present in the industry. Compared with traditional administration methods, the transdermal drug patches have the following advantages: they can produce long-lasting, constant, and controllable blood drug concentration, thereby reducing adverse reactions. Avoid the first-pass effect of the liver and improve the bioavailability of the drug. Alleviate the pain of injection medicine, and avoid diseases transmitted by repeated use of pillows. Patients can use their own medications, and they can stop the medications in time for problems. Reduce the number of doses and dosage. The increasing incidence of chronic diseases and various technological developments in healthcare, pharmaceuticals, and biotechnology are driving the global transdermal patch system market. Some beneficial functions such as non-invasiveness, lower pain of patients, and easy termination of treatment also promote this market. However, transdermal patch systems have various disadvantages, such as irritation and edema at the application site, which may hinder the development of this global market.
In March 2020, Teikoku Pharma USA launched the SECUADO transdermal system for the treatment of adult atypical antipsychotic drugs for schizophrenia. SECUADO is the first-and-only FDA approved transdermal system for schizophrenia.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Transdermal Drug Patches market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Transdermal Drug Patches market. Detailed analysis of key players, along with key growth strategies adopted by Transdermal Drug Patches industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Teikoku Pharma USA
Immune Pharmaceuticals
Xel Pharmaceuticals
DURECT Corporation
Mylan
Johnson & Johnson
Agile Therapeutics
Noven
Novartis
Hercon Pharmaceuticals
Pocono
By Type:
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
By End-User:
Used for Hypertension
Used for Contraception
Used for Analgesia
Used for Smoking Cessation
Used for Angina
Used for Hormone Replacement
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Transdermal Drug Patches Market
-
1.3 Market Segment by Type
-
1.3.1 USA Transdermal Drug Patches Market Size and Growth Rate of Fentanyl Transdermal Patch from 2016 to 2027
-
1.3.2 USA Transdermal Drug Patches Market Size and Growth Rate of Nicotine Transdermal Patch from 2016 to 2027
-
1.3.3 USA Transdermal Drug Patches Market Size and Growth Rate of Buprenorphine Transdermal Patch from 2016 to 2027
-
1.3.4 USA Transdermal Drug Patches Market Size and Growth Rate of Clonidine Transdermal Patch from 2016 to 2027
-
1.3.5 USA Transdermal Drug Patches Market Size and Growth Rate of Oxybutynin Transdermal Patch from 2016 to 2027
-
1.3.6 USA Transdermal Drug Patches Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Transdermal Drug Patches Market Size and Growth Rate of Used for Hypertension from 2016 to 2027
-
1.4.2 USA Transdermal Drug Patches Market Size and Growth Rate of Used for Contraception from 2016 to 2027
-
1.4.3 USA Transdermal Drug Patches Market Size and Growth Rate of Used for Analgesia from 2016 to 2027
-
1.4.4 USA Transdermal Drug Patches Market Size and Growth Rate of Used for Smoking Cessation from 2016 to 2027
-
1.4.5 USA Transdermal Drug Patches Market Size and Growth Rate of Used for Angina from 2016 to 2027
-
1.4.6 USA Transdermal Drug Patches Market Size and Growth Rate of Used for Hormone Replacement from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Transdermal Drug Patches Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Transdermal Drug Patches Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Transdermal Drug Patches Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Transdermal Drug Patches Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Transdermal Drug Patches Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Transdermal Drug Patches by Major Types
-
3.4.1 Market Size and Growth Rate of Fentanyl Transdermal Patch
-
3.4.2 Market Size and Growth Rate of Nicotine Transdermal Patch
-
3.4.3 Market Size and Growth Rate of Buprenorphine Transdermal Patch
-
3.4.4 Market Size and Growth Rate of Clonidine Transdermal Patch
-
3.4.5 Market Size and Growth Rate of Oxybutynin Transdermal Patch
-
3.4.6 Market Size and Growth Rate of Others
4 Segmentation of Transdermal Drug Patches Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Transdermal Drug Patches by Major End-Users
-
4.4.1 Market Size and Growth Rate of Transdermal Drug Patches in Used for Hypertension
-
4.4.2 Market Size and Growth Rate of Transdermal Drug Patches in Used for Contraception
-
4.4.3 Market Size and Growth Rate of Transdermal Drug Patches in Used for Analgesia
-
4.4.4 Market Size and Growth Rate of Transdermal Drug Patches in Used for Smoking Cessation
-
4.4.5 Market Size and Growth Rate of Transdermal Drug Patches in Used for Angina
-
4.4.6 Market Size and Growth Rate of Transdermal Drug Patches in Used for Hormone Replacement
5 Market Analysis by Regions
-
5.1 USA Transdermal Drug Patches Production Analysis by Regions
-
5.2 USA Transdermal Drug Patches Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Transdermal Drug Patches Landscape Analysis
-
6.1 West USA Transdermal Drug Patches Landscape Analysis by Major Types
-
6.2 West USA Transdermal Drug Patches Landscape Analysis by Major End-Users
7 South USA Transdermal Drug Patches Landscape Analysis
-
7.1 South USA Transdermal Drug Patches Landscape Analysis by Major Types
-
7.2 South USA Transdermal Drug Patches Landscape Analysis by Major End-Users
8 Middle West USA Transdermal Drug Patches Landscape Analysis
-
8.1 Middle West USA Transdermal Drug Patches Landscape Analysis by Major Types
-
8.2 Middle West USA Transdermal Drug Patches Landscape Analysis by Major End-Users
9 Northeast USA Transdermal Drug Patches Landscape Analysis
-
9.1 Northeast USA Transdermal Drug Patches Landscape Analysis by Major Types
-
9.2 Northeast USA Transdermal Drug Patches Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Teikoku Pharma USA
-
10.1.1 Teikoku Pharma USA Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Immune Pharmaceuticals
-
10.2.1 Immune Pharmaceuticals Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Xel Pharmaceuticals
-
10.3.1 Xel Pharmaceuticals Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 DURECT Corporation
-
10.4.1 DURECT Corporation Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Mylan
-
10.5.1 Mylan Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Johnson & Johnson
-
10.6.1 Johnson & Johnson Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Agile Therapeutics
-
10.7.1 Agile Therapeutics Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Noven
-
10.8.1 Noven Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Novartis
-
10.9.1 Novartis Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Hercon Pharmaceuticals
-
10.10.1 Hercon Pharmaceuticals Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Pocono
-
10.11.1 Pocono Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Fentanyl Transdermal Patch from 2016 to 2027
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Nicotine Transdermal Patch from 2016 to 2027
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Buprenorphine Transdermal Patch from 2016 to 2027
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Clonidine Transdermal Patch from 2016 to 2027
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Oxybutynin Transdermal Patch from 2016 to 2027
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Used for Hypertension from 2016 to 2027
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Used for Contraception from 2016 to 2027
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Used for Analgesia from 2016 to 2027
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Used for Smoking Cessation from 2016 to 2027
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Used for Angina from 2016 to 2027
-
Figure USA Transdermal Drug Patches Market Size and Growth Rate of Used for Hormone Replacement from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Transdermal Drug Patches Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Transdermal Drug Patches Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Transdermal Drug Patches Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Transdermal Drug Patches Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Transdermal Drug Patches Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Transdermal Drug Patches
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Transdermal Drug Patches by Different Types from 2016 to 2027
-
Table Consumption Share of Transdermal Drug Patches by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Fentanyl Transdermal Patch
-
Figure Market Size and Growth Rate of Nicotine Transdermal Patch
-
Figure Market Size and Growth Rate of Buprenorphine Transdermal Patch
-
Figure Market Size and Growth Rate of Clonidine Transdermal Patch
-
Figure Market Size and Growth Rate of Oxybutynin Transdermal Patch
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Transdermal Drug Patches by Different End-Users from 2016 to 2027
-
Table Consumption Share of Transdermal Drug Patches by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Used for Hypertension
-
Figure Market Size and Growth Rate of Used for Contraception
-
Figure Market Size and Growth Rate of Used for Analgesia
-
Figure Market Size and Growth Rate of Used for Smoking Cessation
-
Figure Market Size and Growth Rate of Used for Angina
-
Figure Market Size and Growth Rate of Used for Hormone Replacement
-
Table USA Transdermal Drug Patches Production by Regions
-
Table USA Transdermal Drug Patches Production Share by Regions
-
Figure USA Transdermal Drug Patches Production Share by Regions in 2016
-
Figure USA Transdermal Drug Patches Production Share by Regions in 2021
-
Figure USA Transdermal Drug Patches Production Share by Regions in 2027
-
Table USA Transdermal Drug Patches Consumption by Regions
-
Table USA Transdermal Drug Patches Consumption Share by Regions
-
Figure USA Transdermal Drug Patches Consumption Share by Regions in 2016
-
Figure USA Transdermal Drug Patches Consumption Share by Regions in 2021
-
Figure USA Transdermal Drug Patches Consumption Share by Regions in 2027
-
Table West USA Transdermal Drug Patches Consumption by Types from 2016 to 2027
-
Table West USA Transdermal Drug Patches Consumption Share by Types from 2016 to 2027
-
Figure West USA Transdermal Drug Patches Consumption Share by Types in 2016
-
Figure West USA Transdermal Drug Patches Consumption Share by Types in 2021
-
Figure West USA Transdermal Drug Patches Consumption Share by Types in 2027
-
Table West USA Transdermal Drug Patches Consumption by End-Users from 2016 to 2027
-
Table West USA Transdermal Drug Patches Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Transdermal Drug Patches Consumption Share by End-Users in 2016
-
Figure West USA Transdermal Drug Patches Consumption Share by End-Users in 2021
-
Figure West USA Transdermal Drug Patches Consumption Share by End-Users in 2027
-
Table South USA Transdermal Drug Patches Consumption by Types from 2016 to 2027
-
Table South USA Transdermal Drug Patches Consumption Share by Types from 2016 to 2027
-
Figure South USA Transdermal Drug Patches Consumption Share by Types in 2016
-
Figure South USA Transdermal Drug Patches Consumption Share by Types in 2021
-
Figure South USA Transdermal Drug Patches Consumption Share by Types in 2027
-
Table South USA Transdermal Drug Patches Consumption by End-Users from 2016 to 2027
-
Table South USA Transdermal Drug Patches Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Transdermal Drug Patches Consumption Share by End-Users in 2016
-
Figure South USA Transdermal Drug Patches Consumption Share by End-Users in 2021
-
Figure South USA Transdermal Drug Patches Consumption Share by End-Users in 2027
-
Table Middle West USA Transdermal Drug Patches Consumption by Types from 2016 to 2027
-
Table Middle West USA Transdermal Drug Patches Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Transdermal Drug Patches Consumption Share by Types in 2016
-
Figure Middle West USA Transdermal Drug Patches Consumption Share by Types in 2021
-
Figure Middle West USA Transdermal Drug Patches Consumption Share by Types in 2027
-
Table Middle West USA Transdermal Drug Patches Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Transdermal Drug Patches Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Transdermal Drug Patches Consumption Share by End-Users in 2016
-
Figure Middle West USA Transdermal Drug Patches Consumption Share by End-Users in 2021
-
Figure Middle West USA Transdermal Drug Patches Consumption Share by End-Users in 2027
-
Table Northeast USA Transdermal Drug Patches Consumption by Types from 2016 to 2027
-
Table Northeast USA Transdermal Drug Patches Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Transdermal Drug Patches Consumption Share by Types in 2016
-
Figure Northeast USA Transdermal Drug Patches Consumption Share by Types in 2021
-
Figure Northeast USA Transdermal Drug Patches Consumption Share by Types in 2027
-
Table Northeast USA Transdermal Drug Patches Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Transdermal Drug Patches Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Transdermal Drug Patches Consumption Share by End-Users in 2016
-
Figure Northeast USA Transdermal Drug Patches Consumption Share by End-Users in 2021
-
Figure Northeast USA Transdermal Drug Patches Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Teikoku Pharma USA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teikoku Pharma USA
-
Figure Sales and Growth Rate Analysis of Teikoku Pharma USA
-
Figure Revenue and Market Share Analysis of Teikoku Pharma USA
-
Table Product and Service Introduction of Teikoku Pharma USA
-
Table Company Profile and Development Status of Immune Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immune Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Immune Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Immune Pharmaceuticals
-
Table Product and Service Introduction of Immune Pharmaceuticals
-
Table Company Profile and Development Status of Xel Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Xel Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Xel Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Xel Pharmaceuticals
-
Table Product and Service Introduction of Xel Pharmaceuticals
-
Table Company Profile and Development Status of DURECT Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of DURECT Corporation
-
Figure Sales and Growth Rate Analysis of DURECT Corporation
-
Figure Revenue and Market Share Analysis of DURECT Corporation
-
Table Product and Service Introduction of DURECT Corporation
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Agile Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agile Therapeutics
-
Figure Sales and Growth Rate Analysis of Agile Therapeutics
-
Figure Revenue and Market Share Analysis of Agile Therapeutics
-
Table Product and Service Introduction of Agile Therapeutics
-
Table Company Profile and Development Status of Noven
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Noven
-
Figure Sales and Growth Rate Analysis of Noven
-
Figure Revenue and Market Share Analysis of Noven
-
Table Product and Service Introduction of Noven
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Hercon Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hercon Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Hercon Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Hercon Pharmaceuticals
-
Table Product and Service Introduction of Hercon Pharmaceuticals
-
Table Company Profile and Development Status of Pocono
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pocono
-
Figure Sales and Growth Rate Analysis of Pocono
-
Figure Revenue and Market Share Analysis of Pocono
-
Table Product and Service Introduction of Pocono
-
